Amlodipine And Valsartan
Product Images NDC 45865-889

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 45865-889). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (889)

Pdp (889)
Amlodipine & Valsartan Tablets 10/160mg are a generic medication used as a replacement for Exforge. More information about this product is not available in this text.*
FDA Label Image

Image-01 (B5a13389 E39e 4825 A6dc 4ba50d432aed 01)

Image-01 (B5a13389 E39e 4825 A6dc 4ba50d432aed 01)
This is a table displaying baseline SBP (measured in mmHg) and medication dosages for Amiodarone, Valsartan, and Kichnep tablets. The top line indicates the target SBP level (<140 mmHg).*
FDA Label Image

Image-02 (B5a13389 E39e 4825 A6dc 4ba50d432aed 02)

Image-02 (B5a13389 E39e 4825 A6dc 4ba50d432aed 02)
This appears to be a medical information sheet with information about a medication called "Amiodipine and Valsartan Tablets" and its dosage indication for the medication. It states that the medication contains 10 mg of Amiodipine and 320 mg of Valsartan. The percentage value of "DBP <90 mmHg" suggests that the medication is prescribed to manage high blood pressure. However, there is not enough information available to provide a comprehensive description, such as the recommended dosage, potential side effects, and contraindications.*
FDA Label Image

Image-03 (B5a13389 E39e 4825 A6dc 4ba50d432aed 03)

Image-03 (B5a13389 E39e 4825 A6dc 4ba50d432aed 03)
This is a graph displaying blood pressure levels of patients under various treatments. The text on the graph indicates that the target blood pressure is less than 130 mmHg. The treatments include Anbodine, Valsartan 250 mg, Valsartan 320 mg, Kaisdne 10, and Placebo. The values on the x-axis represent the baseline SBP (mmHg) of the patients, and the values on the y-axis represent the different treatments. The highest blood pressure levels observed were around 180 mmHg.*
FDA Label Image

Image-04 (B5a13389 E39e 4825 A6dc 4ba50d432aed 04)

Image-04 (B5a13389 E39e 4825 A6dc 4ba50d432aed 04)
The text describes a chart that compares the effects of Amlodipine and Valsartan on DBP (diastolic blood pressure). The chart shows that a combination of Valsartan 320 mg and Amlodipine 10 mg led to a significant reduction in DBP, compared to baseline measurements. A placebo was also used for comparison.*
FDA Label Image

Amlodipineandvals-figure-01 (B5a13389 E39e 4825 A6dc 4ba50d432aed 05)

FDA Label Image

Amlodipineandvals-figure-02 (B5a13389 E39e 4825 A6dc 4ba50d432aed 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.